SUDDS-5
Substance Use Disorders Diagnostic Schedule
Authors: Norman G. Hoffmann, Ph.D., Patricia A. Harrison, PhD
Norman G. Hoffmann, Ph.D.
Norman G. Hoffmann, Ph.D., founder of Evince Diagnostics, is a nationally and internationally recognized expert in the development of practical, scientifically sound assessment instruments and the evaluation of behavioral health treatment programs. His assessment instruments are used throughout the United States, Canada, and parts of Europe. The instruments include brief and comprehensive interviews for the identification of mental health and substance use disorders in accordance with current diagnostic criteria as well as treatment planning aids based on the ASAM Criteria.
He has provided consultation services on assessment and evaluation issues for state and federal agencies, corporations and public organizations in the US, Canada, Sweden, and Norway. A popular current area consists of assisting treatment programs in the implementation of empirically driven assessment and information systems to facilitate decision support, outcome documentation, and continuous quality improvement protocols.
Dr. Hoffmann led the team that developed the first placement criteria for multiple levels of care and was the lead author on the first American Society of Addiction Medicine patient placement criteria. His work on treatment evaluation provided evidence for the societal and financial benefits from addictions treatment and a foundation for empirically supported funding of treatment services. Dr. Hoffmann served on first joint accreditation panel for prisons, probation, and parole in the United Kingdom. His publications include more than 200 articles, book chapters, and other publications.
Dr. Hoffmann received his doctorate in clinical psychology from the University of Minnesota. Although employed largely in the private sector, his faculty appointments include the University of Texas Medical Branch, University of Minnesota, and Brown University. He is currently adjunct professor of psychology at Western Carolina University
For upcoming presentations and workshops, to schedule a workshop or presentation, or to get more information concerning consultations, please contact Dr. Hoffmann via evinceassessment@aol.com or by calling 828-454-9960.
- Career Highlights
- C.V.
Patricia A. Harrison, PhD
- Career Highlights
- C.V.
Quantity
Unit Cost
1-10
$7.75
11-50
$7.50
51+
$6.90
The SUDDS-5 is a comprehensive interview that provides detailed documentation of substance-specific DSM-5 diagnostic indications plus age of onset for problems that may support motivational enhancement.
Benefits
- Detailed documentation of events, behaviors and experiences for substance use disorders
- Age of onset for problems by substance to support motivational enhancement
- Option to have patient sign output attesting to the accuracy of what was reported
- Exploration of current stressors
- Brief screening for common co-occurring conditions: depression, PTSD, and anxiety
- Demographic and clinical prognostic indicators to inform treatment planning
- Address aspects of ASAM Criteria Dimensions 1, 3, and 5
Conditions Covered
- Comprehensive coverage of substance use disorders including age of onset
- Identification of resent stressors
- Documentation of major depressive episode
- Screening for anxiety and PTSD
Application
Initial clinical intake: The SUDDS‐5 is an ideal tool for performing a detailed substance use disorder assessment as part of any routine clinical intake.
Documentation of severity: The DSM‐5 defines severity for substance use disorders in terms of the number of positive diagnostic criteria. Research has also documented that five of the eleven criteria are more strongly associated with a severe diagnosis.
Respondent signoff: The clinician can require that the respondent sign the SUDDS-5 output attesting to the accuracy of the information provided. This makes the SUDDS-5 output an excellent document in cases involving adjudication.
Verification of improvement: Reviewing positive diagnostic findings can determine if the conditions have improved or if remission can be documented.
Informing Dimensions 1, 3, and 5 of the ASAM Criteria:
Dimension 1: The SUDDS‐5 questions on recent use patterns can identify possible withdrawal concerns.
Dimension 3: The screening of the most common co-occurring conditions informs this dimension.
Dimension 5: Both demographic and clinical content covered by the SUDDS‐5 are related to relapse risks after addictions treatment as determined by empirical research.
Motivational enhancement: Reviewing SUDDS‐5 results with clients including age of onset for problems can aid in motivational enhancement. Individuals who are presented with the detailed behaviors and symptoms of their conditions may be more likely to accept referral and become engaged in their treatment plans.
Administration
- Time requirement typically from 35 to 45 minutes depending on the number of positive responses
- Two online administration options:
- Computer prompted - clinician/technician reads questions and enters response
- Computer administered - clinician/technician sets up interview and patient interacts directly with the program
- Paper option: purchase interview in booklet form www.changecompanies.net.
- Training on the use of the paper version available from Evince Diagnostics
- Purchased in packets of 25 interviews with summary form for scoring